Martine Kruijtbosch

195 Gene ra l d i s cu s s i on REFERENCES 1. Hibbert D, Bissell P, Ward PR. Consumerism and professional work in the community pharmacy. Sociol Health Illn 2002;24:46-65. 2. Stevenson FA, Leontowitsch M, Duggan C. Over-the-counter medicines: Professional expertise and consumer discourses. Sociol Health Illn 2008;30:913-928. 3. Pellegrino ED. Patient and physician autonomy: Conflicting rights and obligations in the physician-patient relationship. J Contemp Health Law Policy 1994;10:47-68. 4. Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: Implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom. Res Social Adm Pharm 2009;5:305-318. 5. Rapport F, Doel MA, Hutchings HA, Wright S, Wainwright P, John DN, et al. Eleven themes of patient-centred professionalism in community pharmacy: Innovative approaches to consulting. Int J Pharm Pract . 2010;18:260-268. 6. Tonkens E. Pretenders and performers: Professional responses to the commodification of health care. Soc Theor Health 2013;11:368-387. 7. Roche C, Kelliher F. Giving “Best advice”: Proposing a framework of community pharmacist professional judgement formation. Pharmacy 2014;2:74-85. 8. International Pharmaceutical federation (FIP). Reference document. Pharmacist Ethics and Professional Autonomy: Imperatives for Keeping Pharmacy Aligned with the Public Interest. International Pharmaceutical Federation (FIP), 2014. https://www.fip.org/file/1368. Accessed 15 May 2021. 9. Kälvemark S, Höglund AT, Hansson MG, Westerholm P, Arnetz B. Living with conflicts-ethical dilemmas and moral distress in the health care system. Soc Sci Med 2004;58:1075-1084. 10. Cooper RJ, Bissell P, Wingfield J. Dilemmas in dispensing, problems in practice? Ethical issues and law in UK community pharmacy. Clin Ethics 2007;2:103-108. 11. Cooper RJ, Bissell P, Wingfield J. 'Islands' and 'doctor's tool': The ethical significance of isolation and subordination in UK community pharmacy. Health 2009;13:297-316. 12. Altilio JV. The pharmacist's obligations to patients: Dependent or independent of the physician's obligations? JLME 2009;37:358-368. 13. Sporrong S, Höglund A, Hansson M, Westerholm P, Arnetz B. “We are white coats whirling round” – moral distress in Swedish pharmacies. Pharm World Sci 2005;27:223-229. 14. Astbury JL, Gallagher CT. Moral distress among community pharmacists: Causes and achievable remedies. Res Social Adm Pharm 2020;16:321-328. 15. Kälvemark Sporrong S, Arnetz B, Hansson MG, Westerholm P, Höglund AT. Developing ethical competence in health care organizations. Nurs Ethics 2007;14:825-837. 16. Christodoulou-Fella M, Middleton N, Papathanassoglou EDE, Karanikola MNK. Exploration of the association between nurses’ moral distress and secondary traumatic stress syndrome: Implications for patient safety in mental health services. BioMed Res Int 2017;2017:1908712-19. 17. Pauly B, Varcoe C, Storch J. Framing the issues: Moral distress in health care. HEC Forum 2012;24:1-11.